DE60129425D1 - Kernformulierung - Google Patents

Kernformulierung

Info

Publication number
DE60129425D1
DE60129425D1 DE60129425T DE60129425T DE60129425D1 DE 60129425 D1 DE60129425 D1 DE 60129425D1 DE 60129425 T DE60129425 T DE 60129425T DE 60129425 T DE60129425 T DE 60129425T DE 60129425 D1 DE60129425 D1 DE 60129425D1
Authority
DE
Germany
Prior art keywords
core formulation
rosiglitazone
core
formulation
biguanide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60129425T
Other languages
English (en)
Other versions
DE60129425T2 (de
Inventor
Anthony J Cutie
Akwete L Adjei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeropharm Technology LLC
Original Assignee
Aeropharm Technology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeropharm Technology LLC filed Critical Aeropharm Technology LLC
Publication of DE60129425D1 publication Critical patent/DE60129425D1/de
Application granted granted Critical
Publication of DE60129425T2 publication Critical patent/DE60129425T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Molds, Cores, And Manufacturing Methods Thereof (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
DE60129425T 2000-05-01 2001-05-01 Kernformulierung Expired - Fee Related DE60129425T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US702332 1985-02-15
US20156700P 2000-05-01 2000-05-01
US201567P 2000-05-01
US70233200A 2000-10-31 2000-10-31
PCT/US2001/013988 WO2001082867A2 (en) 2000-05-01 2001-05-01 A core formulation

Publications (2)

Publication Number Publication Date
DE60129425D1 true DE60129425D1 (de) 2007-08-30
DE60129425T2 DE60129425T2 (de) 2008-04-17

Family

ID=26896877

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60129425T Expired - Fee Related DE60129425T2 (de) 2000-05-01 2001-05-01 Kernformulierung

Country Status (8)

Country Link
EP (1) EP1278513B1 (de)
JP (1) JP2004516234A (de)
AT (1) ATE367151T1 (de)
AU (2) AU5745601A (de)
CA (1) CA2407713A1 (de)
DE (1) DE60129425T2 (de)
ES (1) ES2290130T3 (de)
WO (1) WO2001082867A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN192749B (de) * 2002-11-15 2004-05-15 Ranbaxy Lab Ltd
AR045330A1 (es) * 2003-08-07 2005-10-26 Sb Pharmco Inc Forma de dosificacion oral, procedimiento para su preparacion y uso del compuesto 5-(4-(2-(n-metil-n- (2-piridil)amino)etoxi )bencil) tiazolidin-2,4-diona o una sal o solvato farmaceuticamente aceptable del mismo para prepararla
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
US20050163842A1 (en) * 2003-12-31 2005-07-28 Garth Boehm Rosiglitazone and metformin formulations
WO2005065654A2 (en) * 2003-12-31 2005-07-21 Alpharma, Inc. Rosiglitazone formulations
FR2896159B1 (fr) * 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
AR076540A1 (es) * 2009-05-01 2011-06-22 Eurand Inc Composiciones de comprimidos de desintegracion oral que comprenden combinaciones de analgesicos no- opioides y opioides, forma de dosificacion. metodo de preparacion. metodo para tratar dolor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166800A (en) * 1977-08-25 1979-09-04 Sandoz, Inc. Processes for preparation of microspheres
CA2069644A1 (en) * 1990-01-30 1991-07-31 Jan Feijen Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
BR9810172A (pt) * 1997-06-18 2000-08-08 Smithkline Beecham Plc Tratamento de diabete com tiazolidinadiona e metformina
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
AR030920A1 (es) * 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
WO2001035940A2 (en) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride

Also Published As

Publication number Publication date
JP2004516234A (ja) 2004-06-03
ES2290130T3 (es) 2008-02-16
EP1278513A2 (de) 2003-01-29
AU5745601A (en) 2001-11-12
EP1278513B1 (de) 2007-07-18
AU2001257456B2 (en) 2006-02-09
DE60129425T2 (de) 2008-04-17
ATE367151T1 (de) 2007-08-15
EP1278513A4 (de) 2005-01-26
WO2001082867A2 (en) 2001-11-08
CA2407713A1 (en) 2001-11-08
WO2001082867A3 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
WO2001082875A3 (en) A core formulation
BR0012206B1 (pt) artigo fotocrâmico revestido e artigo fotocrâmico.
BR0214972B1 (pt) artigo absorvente.
HK1044694A1 (en) Double eyelid forming article, the manufacturing method and the use thereof.
BR0105361B1 (pt) artigo absorvente.
BR0100865B1 (pt) artigo absorvente.
ITTO20010005A0 (it) Formulazione farmaceutica.
BR0016218B1 (pt) artigo para fumar.
BR0100151B1 (pt) artigo absorvente.
BR0210193B1 (pt) pelÍcula formada a vÁcuo e artigo absorvente.
IT1319241B1 (it) Oggetto decorativo, in particolare di gioielleria.
BR0212253B1 (pt) material e artigo para fumar.
BR0100961B1 (pt) artigo absorvente.
BR0208970B1 (pt) produto absorvente com ajuste melhorado.
BR0208971B1 (pt) produto absorvente com ajuste melhorado.
BR0208969B1 (pt) produto absorvente com ajuste melhorado.
BR0200521B1 (pt) artigo higiênico.
BR0102028B1 (pt) artigo absorvente.
DE60129425D1 (de) Kernformulierung
BR0100962B1 (pt) artigo absorvente.
ITTO20000385A0 (it) Composizione pesticida.
ITTO20000465A0 (it) Confezione per articoli igienico-sanitari e relativo procedimento di fabbricazione.
BR0107047B1 (pt) artigo absorvente.
ITTO20000386A0 (it) Composizione pesticida.
MXPA03000975A (es) Composicion farmaceutica.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee